Dr. Orlin Sergev, MD (he/him) is an Endocrinologist in Summerville, SC with over 17 years of experience. What is your opinion of Dr. Orlin Sergev, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Orlin Sergev, MD has received over $66,260 which includes payments from the following companies:
$31,879.48 from Takeda Pharmaceuticals America, Inc.
$11,286.77 from Tandem Diabetes Care, Inc.
$5,681.23 from AstraZeneca Pharmaceuticals LP
$4,039.88 from Boehringer Ingelheim Pharmaceuticals, Inc.
$3,468.74 from AbbVie, Inc.
$3,147.28 from LILLY USA, LLC
$2,776.08 from Takeda Pharmaceuticals U.S.A., Inc.
$634.66 from Medtronic MiniMed, Inc.
$522.20 from Novo Nordisk Inc
$517.13 from INSULET CORPORATION
$324.31 from IBSA Pharma Inc.
$220.42 from sanofi-aventis U.S. LLC
$138.51 from Radius Health, Inc.
$125.84 from MannKind Corporation
$122.30 from Merck Sharp & Dohme Corporation
$113.64 from Amgen Inc.
$110.06 from Alexion Pharmaceuticals, Inc.
$107.41 from Shire North American Group Inc
$104.52 from Animas Corporation
$91.42 from Antares Pharma, Inc.
Payments received by Dr. Orlin Sergev, MD were from the following categories:
$27,300.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!